{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:30:14Z","timestamp":1794493814869,"version":"4.9.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["VisionGen"],"award-info":[{"award-number":["VisionGen"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010264","name":"Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY033005"],"award-info":[{"award-number":["R01EY033005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21EY036199"],"award-info":[{"award-number":["R21EY036199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ogla.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:53:01Z","timestamp":1785253981000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraocular Pressure Elevation after Suprachoroidal Triamcinolone Acetonide in Noninfectious Uveitis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-4245","authenticated-orcid":false,"given":"Amin","family":"Nabavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-6602","authenticated-orcid":false,"given":"Swarup S.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-5881","authenticated-orcid":false,"given":"Janet L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-2720","authenticated-orcid":false,"given":"Felipe A.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-5730","authenticated-orcid":false,"given":"Siamak","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ogla.2026.07.009_bib1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2024.02.019","article-title":"Treatment of noninfectious uveitic macular edema with periocular and intraocular corticosteroid therapies","volume":"131","author":"Smith","year":"2024","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ogla.2026.07.009_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.oret.2022.12.009","article-title":"A comparison of ocular complications after 0.7 mg dexamethasone implant versus 2 mg of intravitreal triamcinolone in vitrectomized eyes","volume":"7","author":"Wakabayashi","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ogla.2026.07.009_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/IAE.0000000000002361","article-title":"Ocular hypertension after intravitreal injection of 2-MG triamcinolone","volume":"40","author":"Storey","year":"2020","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ogla.2026.07.009_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ogla.2026.07.009_bib5","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ophtha.2007.05.037","article-title":"Adverse events after intravitreal triamcinolone in patients with and without uveitis","volume":"114","author":"Galor","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ogla.2026.07.009_bib6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s40123-022-00525-8","article-title":"Real-life efficacy, safety, and use of dexamethasone intravitreal implant in posterior segment inflammation due to non-infectious uveitis (LOUVRE 2 Study)","volume":"11","author":"Bodaghi","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ogla.2026.07.009_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ajo.2022.10.008","article-title":"A 1-Year retrospective case series of Fluocinolone acetonide 0.18-mg injectable intravitreal implant in chronic uveitis","volume":"246","author":"Andrews","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ogla.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ophtha.2018.10.033","article-title":"Effect of an injectable fluocinolone acetonide insert on recurrence rates in chronic noninfectious uveitis affecting the posterior segment","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ogla.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ogla.2026.07.009_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jop.2021.0090","article-title":"Suprachoroidal injection of triamcinolone acetonide suspension: ocular pharmacokinetics and distribution in rabbits demonstrates high and durable levels in the chorioretina","volume":"38","author":"Muya","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ogla.2026.07.009_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ogla.2026.07.009_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/bjophthalmol-2020-318019","article-title":"Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)","volume":"106","author":"Henry","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.07.009_bib13","first-page":"1139","article-title":"Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)","volume":"106","author":"Khurana","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ogla.2026.07.009_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/IAE.0000000000004677","article-title":"Real-world incidence and management of ocular hypertension after suprachoroidal triamcinolone acetonide injection for macular edema in noninfectious uveitis","volume":"46","author":"Hamdan","year":"2026","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ogla.2026.07.009_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/IAE.0000000000004688","article-title":"Efficacy and safety of suprachoroidal triamcinolone acetonide in mixed etiology noninfectious cystoid macular edema","volume":"46","author":"Yamamoto","year":"2026","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ogla.2026.07.009_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/IAE.0000000000001369","article-title":"Safety of intravitreal dexamethasone implant (OZURDEX)","volume":"37","author":"Malcl\u00e8s","year":"2017","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ogla.2026.07.009_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/IAE.0000000000002901","article-title":"Uveitis treated with dexamethasone implant","volume":"41","author":"Mathis","year":"2021","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ogla.2026.07.009_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ophtha.2017.12.038","article-title":"Dexamethasone inserts in noninfectious uveitis","volume":"125","author":"Pohlmann","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ogla.2026.07.009_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09273948.2019.1578380","article-title":"Long-term intravitreal dexamethasone implant outcomes in uveitis","volume":"28","author":"Alba-Linero","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.ogla.2026.07.009_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3928\/23258160-20180831-05","article-title":"Secondary ocular hypertension and the risk of glaucoma surgery after dexamethasone intravitreal implant in routine clinical practice","volume":"49","author":"Hemarat","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:45:33Z","timestamp":1788378333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419626001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"alternative-id":["S2589419626001304"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2026.07.009","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraocular Pressure Elevation after Suprachoroidal Triamcinolone Acetonide in Noninfectious Uveitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}